SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-23-012337
Filing Date
2023-07-27
Accepted
2023-07-27 06:02:39
Documents
79
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K argx-20230630x6k.htm 6-K 35210
2 EX-99.1 argx-20230630xex99d1.htm EX-99.1 125472
3 EX-99.2 argx-20230630xex99d2.htm   iXBRL EX-99.2 1179015
4 GRAPHIC argx-20230630xex99d1001.jpg GRAPHIC 3320
  Complete submission text file 0001558370-23-012337.txt   5085070

Data Files

Seq Description Document Type Size
5 EX-101.SCH argx-20230630.xsd EX-101.SCH 60541
6 EX-101.CAL argx-20230630_cal.xml EX-101.CAL 67796
7 EX-101.DEF argx-20230630_def.xml EX-101.DEF 119489
8 EX-101.LAB argx-20230630_lab.xml EX-101.LAB 355409
9 EX-101.PRE argx-20230630_pre.xml EX-101.PRE 255075
73 EXTRACTED XBRL INSTANCE DOCUMENT argx-20230630xex99d2_htm.xml XML 838382
Mailing Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 231115126
SIC: 2836 Biological Products, (No Diagnostic Substances)